Hemostasis and malignancy : Hypercoagulability: Diagnosis and clinical managementFRANCIS, J. L; BIGGERSTAFF, J; AMIRKHOSRAVI, A et al.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 93-109, issn 0094-6176Conference Paper

Thrombin and antithrombotics : Hypercoagulability: Diagnosis and clinical managementFENTON, J. W; OFOSU, F. A; BREZNIAK, D. V et al.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 87-91, issn 0094-6176Conference Paper

Hypercoagulability: Diagnosis and clinical managementMAMMEN, Eberhard F.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 87-174, issn 0094-6176Conference Proceedings

Is coronary artery disease initiated perinatally? : Hypercoagulability: Diagnosis and clinical managementLEISTIKOW, E. A.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 139-143, issn 0094-6176Conference Paper

Pharmacological actions of sulodexide : Hypercoagulability: Diagnosis and clinical managementOFOSU, F. A.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 127-138, issn 0094-6176Conference Paper

Use of the electron microscope for diagnosis of platelet disorders : Hypercoagulability: Diagnosis and clinical managementWHITE, J. G.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 163-168, issn 0094-6176Conference Paper

Laboratory investigation of hypercoagulability : Hypercoagulability: Diagnosis and clinical managementFRANCIS, J. L.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 111-126, issn 0094-6176Conference Paper

Research and development commitments in an integrated plasma collection and plasma fractionation environment : Hypercoagulability: Diagnosis and clinical managementRADOSEVICH, M.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 157-161, issn 0094-6176Conference Paper

Comparative in vitro investigation of prothrombin complex concentratesRÖMISCH, J; BONIK, K; MULLER, H.-G et al.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 175-181, issn 0094-6176Conference Paper

Therapeutic use of antithrombin concentrate in sepsisBALK, R; EMERSON, T; FOURRIER, F et al.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 183-194, issn 0094-6176Conference Paper

The role of secondary growth factor production in thrombin-induced proliferation of vascular smooth muscle cells : Hypercoagulability: Diagnosis and clinical managementSTOUFFER, G. A; RUNGE, M. S.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 145-150, issn 0094-6176Conference Paper

Transcellular signaling and pharmacological modulation of thrombin-induced production of plasminogen activator inhibitor-1 in vascular smooth muscle cells : Hypercoagulability: Diagnosis and clinical managementSHEN, G. X; SONG REN; FENTON, J. W et al.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 151-156, issn 0094-6176Conference Paper

PFA-100^TM system : A new method for assessment of platelet dysfunctionMAMMEN, E. F; COMP, P. C; GOSSELIN, R et al.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 2, pp 195-202, issn 0094-6176Conference Paper